Novo Nordisk Investigational Site

Wilmington, North Carolina 28401

We've found

1 trials

at this facility

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Wilmington, NC

Use our guide to learn which trials are right for you!